Serum free IgE guided dose reduction of omalizumab: a case report

Serum free IgE guided dose reduction of omalizumab: a case report

Abstract Background Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that is used for severe asthma patients who are allergic t...

Full description

Bibliographic Details
Main Authors: Yasuhiro Gon, Reiko Ito, Shuichiro Maruoka, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Yuko Iida, Sotaro Shikano, Shu Hashimoto
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Bronchial asthma
Omalizumab
IgE
Online Access:http://link.springer.com/article/10.1186/s13223-017-0211-z

Internet

http://link.springer.com/article/10.1186/s13223-017-0211-z

Similar Items